Business Description
Shanghai Bio-heart Biological Technology Co Ltd
ISIN : CNE100004JH3
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 275.08 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 23.1 | |||||
3-Year EPS without NRI Growth Rate | 25.9 | |||||
3-Year FCF Growth Rate | -3.7 | |||||
3-Year Book Growth Rate | -1.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.95 | |||||
9-Day RSI | 47.56 | |||||
14-Day RSI | 45.7 | |||||
6-1 Month Momentum % | -10.05 | |||||
12-1 Month Momentum % | -53.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 24.62 | |||||
Quick Ratio | 24.39 | |||||
Cash Ratio | 18.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 3.81 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -15.11 | |||||
ROA % | -13.81 | |||||
ROIC % | -19.03 | |||||
ROC (Joel Greenblatt) % | -122.58 | |||||
ROCE % | -14.92 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.53 | |||||
Price-to-Tangible-Book | 0.86 | |||||
EV-to-EBIT | -0.98 | |||||
EV-to-EBITDA | -1.09 | |||||
EV-to-FCF | -1.24 | |||||
Price-to-Net-Current-Asset-Value | 1.28 | |||||
Price-to-Net-Cash | 1.79 | |||||
Earnings Yield (Greenblatt) % | -102.04 | |||||
FCF Yield % | -29.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shanghai Bio-heart Biological Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | |||
EPS (TTM) (HK$) | -0.523 | ||
Beta | 0 | ||
Volatility % | 39.19 | ||
14-Day RSI | 45.7 | ||
14-Day ATR (HK$) | 0.083745 | ||
20-Day SMA (HK$) | 1.752 | ||
12-1 Month Momentum % | -53.23 | ||
52-Week Range (HK$) | 1.26 - 4.27 | ||
Shares Outstanding (Mil) | 243.42 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai Bio-heart Biological Technology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai Bio-heart Biological Technology Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Shanghai Bio-heart Biological Technology Co Ltd Frequently Asked Questions
What is Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185)'s stock price today?
When is next earnings date of Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185)?
Does Shanghai Bio-heart Biological Technology Co Ltd(HKSE:02185) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |